Signos is a health care startup founded in 2018, with the slogan "Weight loss for every body." The company leverages data science to revolutionize weight loss by using continuous glucose monitoring and artificial intelligence to personalize meal and exercise recommendations. The latest milestone for Signos is the $20.00M Series B investment on 21 October 2023, with notable investors including GV, Samsung NEXT, Cheyenne Ventures, Dexcom Ventures, Julian Aiken, and Romello Crowell. Signos' innovative approach offers individuals a tailored path to achieving their desired lifestyle at an affordable price.